Brazil’s Eurofarma Teams With Japan’s Eisai to Bring the Insomnia Drug Dayvigo to Market

Eurofarma has partnered with Japan's Eisai to sell the insomnia drug lemborexant (Dayvigo) in Brazil, targeting a market worth about US$240 million a year.